Table 3.
Association between leukocyturia and symptoms in preceding 2 weeks
| Leukocyturia | Leukocyturia | |||||||
| 0 | + | ++ | 0 | + | ++ | |||
| Total samples (N) | 303 | 32 | 12 | 303 | 32 | 12 | ||
|
OR* per symptomatic day (for increase in postshift leukocyturia, per symptomatic day in 2 preceding weeks (95% CI)) |
OR* for ever symptomatic (for increase in postshift leukocyturia, presence of symptom in 2 preceding weeks (95% CI)) | |||||||
| Symptom | Number of days with symptom in preceding 2-week period Mean (SD) |
At any day in preceding 2-week period experiencing symptom N (%) |
||||||
| Extremely dry mouth | 1.2 (2.4) | 2.1 (3.7) | 4.8 (6.7) | 1.1 (1.0 to 1.3) | 104 (34%) | 12 (38%) | 5 (42%) | 1.1 (0.4 to 3.2) |
| Dysuria | 1.1 (2) | 1.8 (2.5) | 0.7 (1.6) | 1.1 (0.9 to 1.3) | 128 (42%) | 19 (59%) | 2 (17%) | 1.3 (0.5 to 3.2) |
| Little urine | 0.6 (1.8) | 1.7 (2.9) | 2.2 (5.1) | 1.3 (1.1 to 1.5) | 63 (21%) | 15 (47%) | 2 (17%) | 3.9 (1.4 to 10.4) |
| Dark urine | 1.2 (3) | 1.9 (3.2) | 1.5 (3.5) | 1.1 (1.0 to 1.3) | 70 (23%) | 15 (47%) | 3 (25%) | 5.3 (2.0 to 14.3) |
| Cramps | 0.6 (1.7) | 1.3 (2.9) | 0.9 (2.9) | 1.3 (1.1 to 1.5) | 55 (18%) | 12 (38%) | 2 (17%) | 5.8 (1.8 to 18.3) |
| Headache | 1.3 (2.2) | 2.8 (4.1) | 1.6 (1.5) | 1.3 (1.1 to 1.5) | 134 (44%) | 22 (69%) | 9 (75%) | 5.2 (1.8 to 14.5) |
| Fever | 0.3 (0.8) | 1.6 (3.2) | 3.2 (5.4) | 1.5 (1.2 to 1.9) | 41 (14%) | 14 (44%) | 5 (42%) | 3.8 (1.5 to 9.3) |
| Nosebleed | 0 (0.3) | 0.2 (0.9) | 0 (0) | 2.2 (0.9 to 5.4) | 8 (3%) | 2 (6%) | (%) | 2.8 (0.3 to 29.5) |
| Tremor | 0.2 (0.8) | 0.8 (2.9) | 0.3 (0.6) | 1.4 (1.1 to 1.9) | 31 (10%) | 4 (13%) | 2 (17%) | 1.8 (0.5 to 6.3) |
| Hand/Foot inflammation | 0.1 (1) | 0.1 (0.5) | 0.8 (1.6) | 1.1 (0.8 to 1.5) | 13 (4%) | 1 (3%) | 3 (25%) | 2.8 (0.5 to 14.8) |
| Abdominal pain | 0.3 (0.9) | 0.6 (1) | 1.3 (2.7) | 1.7 (1.2 to 2.4) | 42 (14%) | 11 (34%) | 3 (25%) | 3.2 (1.1 to 9.1) |
| Feel like vomiting | 0.3 (0.9) | 0.4 (0.7) | 0.1 (0.3) | 1.4 (0.8 to 2.4) | 47 (16%) | 9 (28%) | 1 (8%) | 2.9 (0.9 to 8.8) |
| Vomiting | 0.1 (0.4) | 0.1 (0.3) | 0.1 (0.3) | 2.1 (0.7 to 6.6) | 17 (6%) | 3 (9%) | 1 (8%) | 4.8 (0.9 to 24.9) |
| Diarrhoea | 0.1 (0.4) | 0.1 (0.4) | 0 (0) | 0.7 (0.2 to 2.5) | 11 (4%) | 2 (6%) | (%) | 0.4 (0.0 to 3.1) |
| Breathing difficulties | 0.4 (1.4) | 0.1 (0.5) | 0 (0) | 0.7 (0.3 to 1.5) | 43 (14%) | 2 (6%) | (%) | 0.4 (0.1 to 2.1) |
| Wheezing | 0.5 (1.7) | 0.2 (0.8) | 0.5 (1.4) | 1.0 (0.7 to 1.3) | 36 (12%) | 2 (6%) | 2 (17%) | 0.9 (0.2 to 3.5) |
| Fainting | 0 (0.1) | 0 (0) | 0 (0) | – | 2 (1%) | (%) | (%) | – |
| Palpitations | 0.4 (1.3) | 0.5 (1.6) | 0.4 (1.4) | 1.0 (0.8 to 1.3) | 38 (13%) | 4 (13%) | 1 (8%) | 0.6 (0.2 to 2.3) |
| Weakness | 0.8 (2) | 1.2 (1.9) | 3.7 (5.7) | 1.1 (1.0 to 1.3) | 72 (24%) | 10 (31%) | 5 (42%) | 1.6 (0.6 to 4.1) |
| Disorientation | 0.2 (1) | 0.1 (0.4) | 0.3 (0.6) | 1.0 (0.6 to 1.6) | 18 (6%) | 1 (3%) | 2 (17%) | 2.4 (0.4 to 14.1) |
| Dizziness | 0.2 (0.9) | 0.5 (1.1) | 2 (4.7) | 1.5 (1.0 to 2.1) | 32 (11%) | 8 (25%) | 2 (17%) | 4.1 (1.3 to 12.7) |
*OR from multinomial mixed effects logistic regression model.